Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon With Therapeutic Hypothermia After Cardiac Arrest
2009-009505-25Phase 2Completed
- Sponsor
- Timo Laitio
- Start
- Feb 2009
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of xenon in Global Brain Ischemia, anoxic encephalopathy and hypoperfusion (2 arms), sponsored by Timo Laitio. Primary endpoints: Brain effects of xenon with therapeutic hypothermia and Neurological outcome after cardiac arrest. Started Feb 2009; status: completed.
02
Drugs
xenon
03
Conditions
Global Brain Ischemiaanoxic encephalopathyhypoperfusion
Beyond the preview
Go deeper on 2009-009505-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009505-25.